Видео ютуба по тегу Constantine Tam

Your Life Matters - Professor Constantine Tam
Your Life Matters - Professor Constantine Tam
Dr. Constantine Tam on the Role of Zanubrutinib in Frontline CLL Treatment,
Dr. Constantine Tam on the Role of Zanubrutinib in Frontline CLL Treatment,
Assoc. Prof. Constantine Tam: Ibrutinib + Venetoclax in R/R MCL - ICML 2017
Assoc. Prof. Constantine Tam: Ibrutinib + Venetoclax in R/R MCL - ICML 2017
Introducing Professor Constantine Tam: Research & Education Lead, Haematology
Introducing Professor Constantine Tam: Research & Education Lead, Haematology
Constantine Tam: Zanubrutinib Active in Treatment-Naïve CLL/SLL
Constantine Tam: Zanubrutinib Active in Treatment-Naïve CLL/SLL
Долгосрочные результаты лечения занубрутинибом у пациентов с ХЛЛ — д-р Константин Там
Долгосрочные результаты лечения занубрутинибом у пациентов с ХЛЛ — д-р Константин Там
Ibrutinib + Venetoclax Treatment for Mantle Cell Lymphoma | Constantine Tam, MD, MBBS | ASH 2023
Ibrutinib + Venetoclax Treatment for Mantle Cell Lymphoma | Constantine Tam, MD, MBBS | ASH 2023
Constantine Tam: Comparing Zanubrutinib With Ibrutinib in Waldenström Macroglobulinemia
Constantine Tam: Comparing Zanubrutinib With Ibrutinib in Waldenström Macroglobulinemia
Lymph Node Size and Outcomes After Ibrutinib-Venetoclax - Dr. Constantine Tam
Lymph Node Size and Outcomes After Ibrutinib-Venetoclax - Dr. Constantine Tam
Dr Constantine Tam: Living with Chronic Lymphocytic Leukaemia (CLL) Part 1 of 4
Dr Constantine Tam: Living with Chronic Lymphocytic Leukaemia (CLL) Part 1 of 4
Asst. Prof. Constantine Tam | ASH 2017 | BGB-3111 in aggressive and indolent NHL
Asst. Prof. Constantine Tam | ASH 2017 | BGB-3111 in aggressive and indolent NHL
ASH 2019 Interview - A/Prof Constantine Tam and Deborah Sims - CLL & Mantle Cell Lymphoma
ASH 2019 Interview - A/Prof Constantine Tam and Deborah Sims - CLL & Mantle Cell Lymphoma
Constantine Tam, MBBS, MD, compares the benefits of zanubrutinib to other BTK inhibitors
Constantine Tam, MBBS, MD, compares the benefits of zanubrutinib to other BTK inhibitors
Dr. Constantine S. Tam on BCL2 Inhibitors Compared to Ibrutinib, Idelalisib
Dr. Constantine S. Tam on BCL2 Inhibitors Compared to Ibrutinib, Idelalisib
Dr Constantine Tam: Living with Chronic Lymphocytic Leukaemia (CLL) Part 2 of 4
Dr Constantine Tam: Living with Chronic Lymphocytic Leukaemia (CLL) Part 2 of 4
Dr Constantine Tam Discusses the Benefits of Zanubrutinib on Cardiac Effects
Dr Constantine Tam Discusses the Benefits of Zanubrutinib on Cardiac Effects
ALPINE Trial: Zanubrutinib vs Ibrutinib in Treating #CLL | Constantine Tam, MD, MBBS | ASH 2023
ALPINE Trial: Zanubrutinib vs Ibrutinib in Treating #CLL | Constantine Tam, MD, MBBS | ASH 2023
Constantine Tam, MBBS, MD, offers his impression of the Phase 2 CAPTIVATE study in CLL from ASH '19
Constantine Tam, MBBS, MD, offers his impression of the Phase 2 CAPTIVATE study in CLL from ASH '19
Constantine Tam, MBBS, MD, regarding the data that lead to the recent FDA approval of zanubrutinib
Constantine Tam, MBBS, MD, regarding the data that lead to the recent FDA approval of zanubrutinib
Constantine Tam, MD & Robert Figlin, MD discuss progress in Waldenstrom’s Macroglobulinemia & ASCO20
Constantine Tam, MD & Robert Figlin, MD discuss progress in Waldenstrom’s Macroglobulinemia & ASCO20
Dr Constantine Tam: Living with Chronic Lymphocytic Leukaemia (CLL) Part 4 of 4
Dr Constantine Tam: Living with Chronic Lymphocytic Leukaemia (CLL) Part 4 of 4